Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014
- PMID: 24048214
Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014
Erratum in
- MMWR Recomm Rep. 2013 Nov 15;62(45):906
Abstract
This report updates the 2012 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccines for the prevention and control of seasonal influenza (CDC. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2012;61:613-8). Routine annual influenza vaccination is recommended for all persons aged ≥ 6 months. For the 2013-14 influenza season, it is expected that trivalent live attenuated influenza vaccine (LAIV3) will be replaced by a quadrivalent LAIV formulation (LAIV4). Inactivated influenza vaccines (IIVs) will be available in both trivalent (IIV3) and quadrivalent (IIV4) formulations. Vaccine virus strains included in the 2013-14 U.S. trivalent influenza vaccines will be an A/California/7/2009 (H1N1)-like virus, an H3N2 virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011, and a B/Massachusetts/2/2012-like virus. Quadrivalent vaccines will include an additional influenza B virus strain, a B/Brisbane/60/2008-like virus, intended to ensure that both influenza B virus antigenic lineages (Victoria and Yamagata) are included in the vaccine. This report describes recently approved vaccines, including LAIV4, IIV4, trivalent cell culture-based inactivated influenza vaccine (ccIIV3), and trivalent recombinant influenza vaccine (RIV3). No preferential recommendation is made for one influenza vaccine product over another for persons for whom more than one product is otherwise appropriate. This information is intended for vaccination providers, immunization program personnel, and public health personnel. These recommendations and other information are available at CDC's influenza website (http://www.cdc.gov/flu); any updates also will be found at this website. Vaccination and health-care providers should check the CDC influenza website periodically for additional information.
Similar articles
-
Prevention and Control of Seasonal Influenza with Vaccines.MMWR Recomm Rep. 2016 Aug 26;65(5):1-54. doi: 10.15585/mmwr.rr6505a1. MMWR Recomm Rep. 2016. PMID: 27560619
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.MMWR Recomm Rep. 2017 Aug 25;66(2):1-20. doi: 10.15585/mmwr.rr6602a1. MMWR Recomm Rep. 2017. PMID: 28841201 Free PMC article.
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.MMWR Recomm Rep. 2018 Aug 24;67(3):1-20. doi: 10.15585/mmwr.rr6703a1. MMWR Recomm Rep. 2018. PMID: 30141464 Free PMC article.
-
Recommendations for Prevention and Control of Influenza in Children, 2018-2019.Pediatrics. 2018 Oct;142(4):e20182367. doi: 10.1542/peds.2018-2367. Epub 2018 Sep 3. Pediatrics. 2018. PMID: 30177511 Review.
-
Recommendations for prevention and control of influenza in children, 2013-2014.Pediatrics. 2013 Oct;132(4):e1089-104. doi: 10.1542/peds.2013-2377. Epub 2013 Sep 2. Pediatrics. 2013. PMID: 23999962 Review.
Cited by
-
Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection.Int J Mol Sci. 2024 May 29;25(11):5909. doi: 10.3390/ijms25115909. Int J Mol Sci. 2024. PMID: 38892096 Free PMC article. Review.
-
Multivalent Epigraph Hemagglutinin Vaccine Protects against Influenza B Virus in Mice.Pathogens. 2024 Jan 23;13(2):97. doi: 10.3390/pathogens13020097. Pathogens. 2024. PMID: 38392835 Free PMC article.
-
Phylogenetic identification of influenza virus candidates for seasonal vaccines.Sci Adv. 2023 Nov 3;9(44):eabp9185. doi: 10.1126/sciadv.abp9185. Epub 2023 Nov 3. Sci Adv. 2023. PMID: 37922357 Free PMC article.
-
The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection-Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures.Viruses. 2023 Sep 20;15(9):1956. doi: 10.3390/v15091956. Viruses. 2023. PMID: 37766362 Free PMC article.
-
The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures.bioRxiv [Preprint]. 2023 Aug 4:2023.08.04.551980. doi: 10.1101/2023.08.04.551980. bioRxiv. 2023. Update in: Viruses. 2023 Sep 20;15(9):1956. doi: 10.3390/v15091956. PMID: 37577630 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
